Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lifecore Biomedical

This article was originally published in The Gray Sheet

Executive Summary

FDA's Medical Device Dispute Resolution Panel meeting is postponed "to permit the resolution of procedural issues and to provide time to adequately address the scientific issues," Lifecore announces May 30. The panel was set to convene June 4 to review the device center's "not approvable" determination for Lifecore's Gynecare Intergel ferric hyaluronate adhesion prevention solution (1"The Gray Sheet" May 14, 2001, In Brief). Under the timeline laid out in CDRH's 1999 draft guidance, MDDRP meetings should take place within 60 days of a decision to assign an issue to the panel. The panel referral was made in February (2"The Gray Sheet" Feb. 12, 2001, In Brief), which puts the device center behind schedule
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT014962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel